Thursday, May 05, 2016 5:57:05 PM
This company continues to bleed shares of stock, seriously diluting common shareholders. This is a doubling of common outstanding shares in just four months. And this is having a dramatic impact on the decline in USRM's stock price, and a corrosive effect on the value of every share held by anyone that owns stock in this company.
Continued losses are primarily funded via very expensive factoring of receivables and convertible notes that are typically converted into common shares.
USRM once again received a "Going Concern" footnote that raises concerns by the auditors about whether company has the resources to continue as a viable company. As quoted directly from the 10Q for March 31, 2016:
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM
Unitronix Corp Unveils Cryptocurrency Investment Portfolio Strategy • UTRX • Oct 2, 2024 8:40 AM
Integrated Ventures, Inc Reports Total 2024 Revenues Of $5,863,935 vs $3,862,849 for 2023. • INTV • Oct 1, 2024 9:00 AM
Nightfood Signs Letter of Intent to Acquire Los Angeles Cooking School, Integrating Automation and Robotics with World-Class Culinary Training • NGTF • Oct 1, 2024 8:30 AM
ZenaTech, Inc. (NASDAQ: ZENA) To Commence Trading Today • COOP • Oct 1, 2024 7:00 AM
Element79 Gold Corp secures loi for launching tailings reprocessing business in Arequipa, Peru • ELMGF • Oct 1, 2024 6:38 AM